Výsledky vyhledávání

Akademický článek

Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling.

Autor: Zhao Y; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Yang Z; Department of Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands., Newcomb L; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Urology, University of Washington, Seattle, Washington, USA., Zheng Y; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Zhu K; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Liu M; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Heijnsdijk EAM; Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Cooperberg M; Department of Urology, University of California, San Francisco, California, USA., Eggener SE; Department of Surgery, University of Chicago Medical Center, Chicago, Illinois, USA., De Marzo AM; Department of Pathology, Oncology and Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kibel AS; Department of Urology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rizopoulos D; Department of Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands., Hall IJ; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Etzioni R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.

Zobrazit plný text záznamu

Akademický článek

PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received ¹⁷⁷ Lu-PSMA-617: Importance of ¹⁸ F-FDG-Avid Discordant Findings.

Autor: Demirci RA; Department of Radiology, University of Washington, Seattle, Washington., Ghodsi A; Department of Radiology, University of Washington, Seattle, Washington., Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Behnia S; Department of Radiology, University of Washington, Seattle, Washington., Nelson PS; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington; and., Cheng HH; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Yezefski TA; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington; and.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Hawley JE; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Montgomery RB; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington., Yu EY; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Schweizer MT; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Chen DL; Department of Radiology, University of Washington, Seattle, Washington., Iravani A; Department of Radiology, University of Washington, Seattle, Washington; airavani@uw.edu.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.

Zobrazit plný text záznamu

Akademický článek

SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving ¹⁷⁷ Lu-PSMA-617.

Autor: Demirci RA; Department of Radiology, University of Washington, Seattle, Washington., Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Hawley JE; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Yezefski T; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington., Haffner MC; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington; and.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Cheng HH; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Montgomery RB; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington., Schweizer MT; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Yu EY; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Nelson PS; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington; and., Chen DL; Department of Radiology, University of Washington, Seattle, Washington., Iravani A; Department of Radiology, University of Washington, Seattle, Washington; airavani@uw.edu.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.

Zobrazit plný text záznamu

Akademický článek

Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2).

Autor: Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University Medical Center, Durham, NC, USA., Taylor A; University of Wisconsin, Madison, WI, USA., Haffner MC; Fred Hutchinson Cancer Center, Seattle, WA, USA., Abida W; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bryce AH; City of Hope, Goodyear, AZ, USA., Karsh LI; The Urology Center of Colorado, Denver, CO, USA., Tagawa ST; Weill Cornell Medicine, New York, NY, USA., Twardowski P; Saint John's Cancer Institute, Santa Monica, CA, USA., Serritella AV; University of Wisconsin, Madison, WI, USA., Lang JM; University of Wisconsin, Madison, WI, USA. jmlang@medicine.wisc.edu.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.

Zobrazit plný text záznamu

Akademický článek

Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2).

Autor: Serritella AV; University of Wisconsin, Madison, WI, USA., Taylor A; University of Wisconsin, Madison, WI, USA., Haffner MC; Fred Hutchinson Cancer Center, Seattle, WA, USA., Abida W; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bryce A; Mayo Clinic Arizona, Phoenix, AZ, USA., Karsh LI; The Colorado Urology Center, Denver, CO, USA., Tagawa ST; Weill Cornell Medicine, New York, NY, USA., Twardowski P; Saint John's Cancer Institute, Santa Monica, CA, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University Medical Center, Durham, NC, USA., Lang JM; University of Wisconsin, Madison, WI, USA. jmlang@medicine.wisc.edu.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání